Cover image of the article: Expression of Concern for Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial [Iran J Pediatr. 2016;26(5): e5743]

Image Credit:Iran J Pediatr

Expression of Concern for Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial [Iran J Pediatr. 2016;26(5): e5743]

Authors

Vahid ZiaeeVahid Ziaee ORCID1,*
1Tehran University of Medical Sciences, Tehran, Iran
*Corresponding Author: Tehran University of Medical Sciences, Tehran, Iran. Email: ziaee@tums.ac.ir

Innovative Journal of Pediatrics:Vol. 34, issue 5; e156756
Published online:Oct 01, 2024
Article type:Expressions of Concern
Received:Oct 01, 2024
Accepted:Oct 01, 2024
How to Cite:Ziaee V. Expression of Concern for Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial [Iran J Pediatr. 2016;26(5): e5743]. Inn J Pediatr. 2024;34(5):e156756. doi: https://doi.org/10.5812/ijp-156756

The Ethics Committee of Brieflands is issuing this Expression of Concern regarding the article titled "Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial " which was published in the IJ Pediatrics Journal (1).
We have been alerted to potential issues regarding the source of the Alveofact used in the study. This concern was reported to us by a whistleblower via ticket #540087, who provided a detailed analysis and evidence supporting these claims.
In light of this serious concern, we are currently conducting a thorough investigation to determine the validity of these allegations. During this period, readers are advised to interpret the findings of the article with caution.
We will provide an update with the results of our investigation and any necessary actions that may follow, including potential retraction of the article if the concerns are substantiated.
We take issues of scientific integrity very seriously and are committed to ensuring the accuracy and reliability of the research published in our journal.
Thank you for your understanding and patience as we address this matter.
Sincerely,
Head of the Ethics Committee
Brieflands

References

  • 1.
    Mussavi M, Mirnia K, Asadollahi K. Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial. Iran J Pediatr. 2016;26(5). e5743. [PubMed ID: 28203337]. [PubMed Central ID: PMC5297380]. https://doi.org/10.5812/ijp.5743.

Copyright

Copyright © 2024, Ziaee. This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

25
Jul
2016
Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial

Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial

Mirhadi Mussavi,
Keyvan Mirnia,
Khairollah Asadollahi

Mussavi M, Mirnia K, Asadollahi K. Comparison of the Efficacy of Three Natural Surfactants (Curosurf, Survanta, and Alveofact) in the Treatment of Respiratory Distress Syndrome Among Neonates: A Randomized Controlled Trial. Inn J Pediatr. 2016;26(5):e5743. doi: https://doi.org/10.5812/ijp.5743

2
Sep
2026
Methodological Concerns Regarding the Reported Superiority of Curosurf® Over BLES® in Preterm Neonates

Methodological Concerns Regarding the Reported Superiority of Curosurf® Over BLES® in Preterm Neonates

Sayed Ali Sina Hashemi,
Mohammadamin Noorafrooz,
Sedigheh Hantoushzadeh

Hashemi SAS, Noorafrooz M, Hantoushzadeh S. Methodological Concerns Regarding the Reported Superiority of Curosurf® Over BLES® in Preterm Neonates. Inn J Pediatr. 2026;36(5):e164073. doi: https://doi.org/10.5812/ijpediatr-164073

13
Apr
2022
Comparison of Surfactant Administration Efficacy in the Treatment of Respiratory Distress Syndrome in Preterm Neonates: Aerosolization Versus INSURE

Comparison of Surfactant Administration Efficacy in the Treatment of Respiratory Distress Syndrome in Preterm Neonates: Aerosolization Versus INSURE

Ali Reza Sadeghnia,
Zarineh Mahjoor,
Behzad Barekatain

Sadeghnia AR, Mahjoor Z, Barekatain B. Comparison of Surfactant Administration Efficacy in the Treatment of Respiratory Distress Syndrome in Preterm Neonates: Aerosolization Versus INSURE. Inn J Pediatr. 2022;32(2):e120633. doi: https://doi.org/10.5812/ijp-120633

8
Feb
2017
Comparison of the Results of Simultaneous Surfactant Administration and Nasal Continuous Positive Airway Pressure (INSURE) and Non-administration of Surfactant for the Treatment of Infants with Respiratory Distress Syndrome

Comparison of the Results of Simultaneous Surfactant Administration and Nasal Continuous Positive Airway Pressure (INSURE) and Non-administration of Surfactant for the Treatment of Infants with Respiratory Distress Syndrome

Shamsollah Noripour,
Amir Molaei,
Razieh Bandari,
Alireza Emadi,
Seyd Majid Farokhi Far,
Mohammad Forozeshfard

Noripour S, Molaei A, Bandari R, Emadi A, Farokhi Far SM, et al. Comparison of the Results of Simultaneous Surfactant Administration and Nasal Continuous Positive Airway Pressure (INSURE) and Non-administration of Surfactant for the Treatment of Infants with Respiratory Distress Syndrome. J Compr Ped. 2017;8(1):e37462. doi: https://doi.org/10.5812/compreped.37462

31
Aug
2017

Comparison of INSURE and Non-Administration of Surfactant for Neonatal Respiratory Distress Syndrome (NRDS)

Anirban Mandal,
Puneet Kaur Sahi

Mandal A, Kaur Sahi P. Comparison of INSURE and Non-Administration of Surfactant for Neonatal Respiratory Distress Syndrome (NRDS). J Compr Ped. 2017;8(3):e62608. doi: https://doi.org/10.5812/compreped.62608

More by these authors

Vahid ZiaeePubMedScholar
Share
Cited by
Metrics